Crossmark

Optimal Therapeutic Strategy for PD-L1 Negative Metastatic Non-Small Cell Lung Cancer: A Decision-Making Guide Based on Clinicopathological and Molecular Features

Crossref DOI link: https://doi.org/10.1007/s11864-023-01132-w

Published Online: 2023-10-06

Published Print: 2023-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Malvicini, Mariana

Vilbert, Maysa Silveira

Minatta, José N.

Costas, Valeria Colomo

Rizzo, Manglio M. https://orcid.org/0000-0003-2829-4701
License Information

Text and Data Mining valid from 2023-10-06

Version of Record valid from 2023-10-06
More Information

Article History

Accepted: 12 August 2023

First Online: 6 October 2023

Compliance with Ethical Standards

:

: The authors declare no competing interests.

: This article does not contain any studies with human or animal subjects performed by any of the authors.

Document is current

Any future updates will be listed below